Latest update

2019-12-11

Last approved inhibitor(s)

Pexidartinib, Entrectinib, Fedratinib, Upadacitinib, Alpelisib

New inhibitor(s) this month

Ceralasertib, Derazantinib, Lazertinib, Pralsetinib, Ripretinib, Rivoceranib, Samotolisib

Sources

Structures and data are compiled by SB&C Team from the Chembl Drugstore and clinicaltrials.gov.
Please note that we provide information about inhibitors having known International Nonproprietary Names (INN). For more information see the USAN nomenclature.

Contact

To report any issue please contact pascal.bonnet@univ-orleans.fr

How to cite PKIDB

Carles, F., Bourg, S., Meyer, C., and Bonnet, P. (2018). PKIDB: A Curated, Annotated and Updated Database of Protein Kinase Inhibitors in Clinical Trials. Molecules 23, 908. DOI: 10.3390/molecules23040908